Top Markets
Coin of the day
Healios K.K. Healios K.K.

Healios K.K.

4593
Rang in aandelen #17186
Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011,... Healios K.K., a Tokyo-based biopharmaceutical firm established in 2011, specializes in the discovery, development, manufacturing, and commercialization of advanced cell and regenerative medical therapies. The company operates across key markets including Japan, Europe, and the United States. Its robust pipeline features several cellular and tissue-based products, such as HLCR011 and HLCR012, which are induced pluripotent stem cell (iPSC)-derived regenerative medicines aimed at treating age-related macular degeneration. Another iPSC-based therapy, HLCL041, is being developed for metabolic liver disease. Furthermore, Healios is progressing HLCM051, a regenerative treatment designed for ischemic stroke and acute respiratory distress syndrome, alongside HLCN061 for solid tumor indications. The company also maintains a joint research partnership with Hyogo Medical University, focusing on eNK cell-based cancer immunotherapies to combat mesothelioma. Healios K.K. adopted its current name in September 2013, having previously operated under the name Retina Institute Japan, K.K.
Aandeelprijs
$1.89
Marktkapitalisatie
$254.55M
Verandering (1 dag)
-2.03%
Verandering (1 jaar)
-48.53%
Land
JP
Handel Healios K.K. (4593)

Categorie

Koersgeschiedenis voor Healios K.K. (4593)
Hoogste slotkoers: $1.91 op 2026-09-01

Laagste slotkoers: $12.24 op 2015-06-01
Koersgeschiedenis van Healios K.K. van 2015 tot 2026
Jaarlijkse koersprestatie
Jaar Prestaties
2026 (TTM) 10.25%
2025 88.62%
2024 -2.29%
2023 -42.34%
2022 -81.62%
2021 -40.66%
2020 45.21%
2019 -16.02%
2018 2.08%
2017 -12.10%
2016 85.34%
2015 0.00%
Aandelenkoers van vergelijkbare bedrijven of concurrenten
Bedrijf Aandelenkoers Verandering 1jr% Land
$550.56 37.30%
US
$1.05K 47.97%
NL
$122.21 -10.03%
AU
$146.95 507.48%
US
$757.71 8.20%
CH